Roles of R-Loop Structures in Cellular Function and Disease Progression

Our group's research focuses on R-loops , dynamic and fascinating three-stranded nucleic acid structures that form within the genomic DNA of all cells. R-loops pose barriers to DNA replication, and their improper accumulation or persistence is thus thought to contribute to disease by causing DNA damage and genome instability. At the same time, however, an abundance of evidence has revealed that these structures play essential roles in normal cellular homeostasis as well. We aim to further uncover these cellular functions and explore how their dysregulation contributes to pathogenesis and disease progression.

One fundamental aspect of our research is identifying cellular interactors of R-loops . We are particularly interested in R-loop "readers": enzymes that bind and/or recognize R-loops in order to connect them to downstream pathways such as gene regulation, chromatin remodeling, or DNA repair. Identifying these readers is crucial to understanding how R-loops are integrated into their cellular roles; elucidating how mutations in readers can impact R-loop mediated function; and developing therapies that target R-loop related vulnerabilities in disease. We utilize innovative proximity labeling strategies, proteomic screens, and cell knockout models to answer these questions.

We are also exploring an emerging and exciting role for R-loops in the regulation of genome organization . R-loops can bolster the binding of CTCF, a master chromatin architectural protein that facilitates 3D organization of the genome at multiple scales. This recent discovery opens up the tantalizing possibility that R-loop accumulation, in addition to consequences on DNA damage and genome stability, may contribute to disease progression by rewiring the 3D genome into a configuration that supports pathogenic gene expression. We are examining this hypothesis by combining cutting-edge genomic sequencing methods to probe how R-loops, CTCF, and chromatin conformation change in tandem upon perturbation in disease models.

Our experimental approaches interface molecular biology with high-throughput genomic sequencing, generating and using cell lines to model R-loop dynamics in disease with a focus on breast and ovarian cancer. Lab members receive extensive depth and breadth of training in the full bench-to-computation pipeline of genomics work, encompassing both wet-lab experimental techniques and dry-lab bioinformatic analysis. Our research will shed light on the fundamentals of R-loop mediated cellular regulation and identify therapeutic targets for diseases and disorders in which R-loops accumulate.

Thumb
Phillip Wulfridge